Novavax’s stock soars 51% after positive COVID and flu trial data and news of plan to lay off 25% of workforce
May 09, 2023 at 10:36 AM EDT
The news helped ease fears raised by the company's "going-concern" language earlier this year.
Photography by Christophe Tomatis